ENVB (STOCKS)
Enveric Biosciences, Inc. Common Stock
$1.973900
-0.016100 (-0.81%)
Prev close: $1.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Joseph Tucker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.72M
- Employees
- 6
- P/E (TTM)
- -0.05
- P/B (TTM)
- 0.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-57.60 | $-2.82 | -54.7848 | -1,946.04% |
|
Sep 2024 (Q3)
|
$-43.20 | $-95.47 | +52.2720 | +54.75% |
|
Jun 2024 (Q2)
|
$-45.00 | $-100.98 | +55.9800 | +55.44% |
|
Mar 2024 (Q1)
|
$-109.80 | $-142.29 | +32.4900 | +22.83% |
Financial Statements
| Revenues | -$106.00 |
| Benefits Costs and Expenses | $8.77M |
| Costs And Expenses | $8.77M |
| Nonoperating Income/Loss | $2.46K |
| Operating Expenses | $8.77M |
| Depreciation and Amortization | $200.86K |
| Research and Development | $2.78M |
| Other Operating Expenses | $5.79M |
| Operating Income/Loss | -$8.77M |
| Income/Loss From Continuing Operations After Tax | -$8.77M |
| Income/Loss From Continuing Operations Before Tax | -$8.77M |
| Interest Income/Expense After Provision For Losses | -$106.00 |
| Interest Income/Expense Operating, Net | -$106.00 |
| Net Income/Loss | -$8.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $3.36M |
| Preferred Stock Dividends And Other Adjustments | $3.36M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$36.24 |
| Diluted Earnings Per Share | -$36.24 |
| Basic Average Shares | 334,719 |
| Diluted Average Shares | 334,719 |
| Assets | $5.10M |
| Current Assets | $4.94M |
| Noncurrent Assets | $159.23K |
| Fixed Assets | $159.23K |
| Liabilities | $918.40K |
| Current Liabilities | $918.40K |
| Accounts Payable | $581.02K |
| Other Current Liabilities | $337.38K |
| Noncurrent Liabilities | $0.00 |
| Equity | $4.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.18M |
| Liabilities And Equity | $5.10M |
| Net Cash Flow From Operating Activities | -$8.14M |
| Net Cash Flow From Operating Activities, Continuing | -$8.14M |
| Net Cash Flow From Investing Activities | -$2.44M |
| Net Cash Flow From Investing Activities, Continuing | -$2.44M |
| Net Cash Flow From Financing Activities | $10.58M |
| Net Cash Flow From Financing Activities, Continuing | $10.58M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.76M |
| Other Comprehensive Income/Loss | -$8.76M |